NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
4basebio UK Societas (LSE: 4BB)
4BB Technical Analysis
5
As on 21st Nov 2024 4BB STOCK Price closed @ 1300.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 687.27 & Strong Buy for SHORT-TERM with Stoploss of 582.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4BBSTOCK Price
Open | 1300.00 | Change | Price | % |
High | 1310.00 | 1 Day | 0.00 | 0.00 |
Low | 1300.00 | 1 Week | 25.00 | 1.96 |
Close | 1300.00 | 1 Month | -90.00 | -6.47 |
Volume | 2 | 1 Year | 730.00 | 128.07 |
52 Week High 1820.00 | 52 Week Low 500.00 |
LSE UK Most Active Stocks
NTOG | 0.02 | -50.00% |
TRP | 0.03 | 0.00% |
VELA | 0.01 | % |
MSMN | 0.04 | 0.00% |
UKOG | 0.02 | 0.00% |
RRR | 0.04 | 0.00% |
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
DMTR | 0.03 | 0.00% |
BOIL | 0.08 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
4BB Daily Charts |
4BB Intraday Charts |
Whats New @ Bazaartrend |
4BB Free Analysis |
|
4BB Important Levels Intraday
RESISTANCE | 1319.27 |
RESISTANCE | 1313.09 |
RESISTANCE | 1309.27 |
RESISTANCE | 1305.45 |
SUPPORT | 1294.55 |
SUPPORT | 1290.73 |
SUPPORT | 1286.91 |
SUPPORT | 1280.73 |
4BB Forecast November 2024
4th UP Forecast | 1511.97 |
3rd UP Forecast | 1443.99 |
2nd UP Forecast | 1401.97 |
1st UP Forecast | 1359.95 |
1st DOWN Forecast | 1240.05 |
2nd DOWN Forecast | 1198.03 |
3rd DOWN Forecast | 1156.01 |
4th DOWN Forecast | 1088.03 |
4BB Weekly Forecast
4th UP Forecast | 1338.54 |
3rd UP Forecast | 1326.18 |
2nd UP Forecast | 1318.54 |
1st UP Forecast | 1310.90 |
1st DOWN Forecast | 1289.10 |
2nd DOWN Forecast | 1281.46 |
3rd DOWN Forecast | 1273.82 |
4th DOWN Forecast | 1261.46 |
4BB Forecast2024
4th UP Forecast | 3859.06 |
3rd UP Forecast | 3038.35 |
2nd UP Forecast | 2531.06 |
1st UP Forecast | 2023.76 |
1st DOWN Forecast | 576.24 |
2nd DOWN Forecast | 68.94 |
3rd DOWN Forecast | -438.35 |
4th DOWN Forecast | -1259.06 |
4basebio UK Societas ( LSE UK Symbol : 4BB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4BB Other Details
Segment | EQ | |
Market Capital | 86838376.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
4BB Address
4BB Latest News
4BB Business Profile
4basebio UK Societas develops gene therapy technologies and solutions primarily in the United Kingdom. It focuses on the manufacture and supply of synthetic DNA and non-viral nanoparticles for research, therapeutic, and pharmacological use. The company provides services for biotech and pharma customers in the gene therapy and gene vaccine development. It is also involved in the manufacture of enzymes that are used for diagnostic and laboratory test kits. The company was formerly known as 4Basebio SE and changed its name to 4basebio UK Societas in December 2020. 4basebio UK Societas was incorporated in 2020 and is based in Cambridge, United Kingdom. Address: 25 Norman Way, Cambridge, United Kingdom, CB24 5QE
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service